Novogen Limited Release: U.S. Studies Confirm Ability Of TRXE-009 To Kill Brain Cancer Stem Cells

The latest study looked at the ability of TRXE-009 to kill a library of patient-derived cell cultures from subjects with glioblastoma multiform . The cells were cultured under conditions that promote cancer stem cell growth.

http://ift.tt/1DUoaiF